ROCK-II inhibitors (The First Affiliated Hospital of Nanjing Medical University/The Affiliated Hospital of Nantong University/China Pharmaceutical University)

N/A

Report date: 2025/01/26 17:03:57
NME

Base Information

Drug NameROCK-II inhibitors (The First Affiliated Hospital of Nanjing Medical University/The Affiliated Hospital of Nantong University/China Pharmaceutical University)
Drug Alias Namefasudil dichloroacetateFDCA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Other Information

ATC CodeN/A
Related LinksN/A